Early research (Phase 1)WithdrawnNCT04741984What this trial is testingMonocyte Antigen Carrier Cells for Newly Diagnosed GBMWho this might be right forGlioblastomaGlioma, Malignant Michael Gunn
Large-scale testing (Phase 3)Looking for participantsNCT03970447What this trial is testingA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaWho this might be right forGlioblastoma Global Coalition for Adaptive Research 2,250
Very early researchStudy completedNCT05432375What this trial is testingStudy of Tinostamustine for Adjuvant Treatment of GlioblastomaWho this might be right forGlioblastoma Multiforme Mundipharma Research Limited 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06388733What this trial is testingA Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaWho this might be right forGlioblastomaGBMBrain Neoplasms, Adult, Malignant+1 more Ivy Brain Tumor Center 450
Early research (Phase 1)Ended earlyNCT03250299What this trial is testingMicrotubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaWho this might be right forGlioblastomaMGMT-Unmethylated Glioblastoma Basilea Pharmaceutica 26
Testing effectiveness (Phase 2)UnknownNCT02928575What this trial is testingCombining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With GlioblastomaWho this might be right forGlioblastoma Multiforme Bassam Abdulkarim 45
Early research (Phase 1)Study completedNCT03726515What this trial is testingCART-EGFRvIII + Pembrolizumab in GBMWho this might be right forGlioblastoma University of Pennsylvania 7
Testing effectiveness (Phase 2)Study completedNCT03522298What this trial is testingSafety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed GlioblastomaWho this might be right forGlioblastoma, Adult Kazia Therapeutics Limited 30
Testing effectiveness (Phase 2)Looking for participantsNCT03643549What this trial is testingBortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)Who this might be right forGlioblastoma Haukeland University Hospital 63
Early research (Phase 1)Looking for participantsNCT07343986What this trial is testingStudy of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated GlioblastomaWho this might be right forGlioblastoma (GBM) University of Virginia 12
Large-scale testing (Phase 3)Looking for participantsNCT07452458What this trial is testingTemporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated GlioblastomaWho this might be right forGlioblastoma, IDH-WildtypeMGMT-Unmethylated Glioblastoma NRG Oncology 398
Testing effectiveness (Phase 2)Study completedNCT03050736What this trial is testingSafety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT ExpressionWho this might be right forGliomaGlioblastomaGlioblastoma Multiforme+2 more Kintara Therapeutics, Inc. 29
Testing effectiveness (Phase 2)UnknownNCT04224441What this trial is testingRepurposing Chlorpromazine in the Treatment of GlioblastomaWho this might be right forGlioblastoma MultiformeMGMT-Unmethylated Glioblastoma Marco G Paggi, MD, PhD 41
Testing effectiveness (Phase 2)Looking for participantsNCT07476794What this trial is testingDaily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatomaWho this might be right forGlioblastoma Sunnybrook Health Sciences Centre 118
Testing effectiveness (Phase 2)Ended earlyNCT01044225What this trial is testingEffect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated GlioblastomaWho this might be right forGlioblastoma Bart Neyns 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04121455What this trial is testingGlioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated PatientsWho this might be right forGlioblastoma TME Pharma AG 117
Testing effectiveness (Phase 2)Looking for participantsNCT05734560What this trial is testingD2C7-IT and 2141-V11 in Newly Diagnosed GBM PatientsWho this might be right forNewly Diagnosed MGMT Unmethylated Glioblastoma Darell Bigner 50
Testing effectiveness (Phase 2)Looking for participantsNCT06504381What this trial is testingDB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade GliomaWho this might be right forHigh Grade GliomaMGMT-Unmethylated GlioblastomaMGMT-Methylated Glioblastoma University of California, San Francisco 70
Early research (Phase 1)Active Not RecruitingNCT05743595What this trial is testingNeoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated GlioblastomaWho this might be right forUnmethylated Glioblastoma Washington University School of Medicine 27
Early research (Phase 1)Active Not RecruitingNCT05236036What this trial is testingMycophenolate Mofetil in Combination With Standard of Care for the Treatment of GlioblastomaWho this might be right forAstrocytomaGlioblastomaGlioblastoma, IDH-Wildtype+2 more Northwestern University 86